Hektas Ticaret - Public Comps and Valuation Multiples

Hektas Ticaret Overview

About Hektas Ticaret

Hektas Ticaret AS is a Turkey-based company involved in producing and marketing agricultural and veterinary medicines. Its offerings include agrochemicals, such as insecticides, herbicides, fungicides, leaf fertilizers, growth regulators, and fumigants; and veterinary pharmaceuticals. The majority of revenue is derived from domestic sales.

Founded

1956

HQ

Employees

579

Website

hektas.com.tr

Sectors

Agriculture

Financials

Last FY Revenue $115M

Last FY EBITDA $57.7M

EV

$822M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Hektas Ticaret Financials

See Hektas Ticaret valuation multiples based on analyst estimates

Hektas Ticaret P&L

In the most recent fiscal year, Hektas Ticaret reported revenue of $115M and EBITDA of $57.7M.

Hektas Ticaret expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Hektas Ticaret valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$115M	XXX	XXX	XXX
Gross Profit	XXX	-$23.8M	XXX	XXX	XXX
Gross Margin	XXX	-21%	XXX	XXX	XXX
EBITDA	XXX	$57.7M	XXX	XXX	XXX
EBITDA Margin	XXX	50%	XXX	XXX	XXX
EBIT	XXX	-$67.3M	XXX	XXX	XXX
EBIT Margin	XXX	-59%	XXX	XXX	XXX
Net Profit	XXX	-$64.2M	XXX	XXX	XXX
Net Margin	XXX	-56%	XXX	XXX	XXX
Net Debt	XXX	$113M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Hektas Ticaret including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Hektas Ticaret achieved $115M in revenue and $57.7M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$115M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	-$23.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	-20.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$57.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	50.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	-$67.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	-58.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	-$64.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	-56.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$113M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Hektas Ticaret

This financial data table provides comprehensive performance metrics for Hektas Ticaret, a company based in Turkey. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Hektas Ticaret reported $115M in total revenue.
Fiscal year EBITDA was $57.7M.
The company maintained a gross profit margin of -20.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 50.3%.
Net profit margin reached -56.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Hektas Ticaret. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Hektas Ticaret Stock Performance

Hektas Ticaret has current market cap of TRY 26.8B (or $631M), and EV of TRY 34.9B (or $822M).

Market Cap Evolution

Hektas Ticaret Stock Data

As of December 5, 2025, Hektas Ticaret's stock price is TRY 3 (or $0).

See Hektas Ticaret trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$822M	$631M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Hektas Ticaret Valuation Multiples

Hektas Ticaret's trades at 7.2x EV/Revenue multiple, and 14.2x EV/EBITDA.

See valuation multiples for Hektas Ticaret and 15K+ public comps

Hektas Ticaret Financial Valuation Multiples

As of December 5, 2025, Hektas Ticaret has market cap of $631M and EV of $822M.

Equity research analysts estimate Hektas Ticaret's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Hektas Ticaret's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$631M	XXX	$631M	XXX	XXX	XXX
EV (current)	$822M	XXX	$822M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	7.2x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	14.2x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-12.2x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-9.8x	XXX	XXX	XXX
EV/FCF	n/a	XXX	10.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Hektas Ticaret Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Hektas Ticaret Margins & Growth Rates

Hektas Ticaret's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Hektas Ticaret's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Hektas Ticaret's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Hektas Ticaret and other 15K+ public comps

Hektas Ticaret Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	50%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	38%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial